Need help? Order a test
news

Nutrition as a ‘precision medicine’ in cancer treatment

We know that a healthy diet and good nutrition might contribute in reduction of risk of certain cancers. Diets that are high in plant foods – such as fruit, vegetables, wholegrains and beans – may protect against certain cancers. For example, diets with a high proportion of these fibre-rich foods can protect against bowel cancer. […]

Read more
news

Liquid biopsy blood tests could be used to diagnose brain tumours

Results of a promising trial in people with brain tumours suggests that a specific blood test could be used for more accurate diagnosis, without the need for invasive procedures. The blood test based on circulating-tumour DNA (ctDNA) has been found to accurately classify different types of brain tumours and could allow for better treatment planning […]

Read more
news

Simple blood tests can be used to look for resistance to chemotherapy

When it comes to treating cancer, there’s good news and bad news. Part of the good news is that there are many effective medicines, known as chemotherapies, that can treat cancer and improve survival. The not so good news is that some cancers that initially respond to chemotherapy can become resistant to treatment. This means […]

Read more
news

Circulating tumour cells may predict breast cancer outcomes

Breast cancer is the second most common cancer worldwide and there were over 2 million new cases in 2018, according to the World Cancer Research Fund. So there is great research interest in understanding more about what determines how likely people with breast cancer are to survive, and to respond to treatment. Researchers at Cleveland […]

Read more
news

Liquid biopsies shed light on cancer drug resistance

It is not uncommon for people with cancer to have treatment with a drug that is initially effective at shrinking their tumour, only for it to grow back as the cancer cells in the tumour evolve and become resistant to the drugs. It is estimated that drug resistance and the resulting ineffectiveness of treatments are […]

Read more
news

Multi-cancer blood test can detect 26 cancers

In the first study of its kind, researchers have used a simple blood test to safely detect multiple cancers in nearly 10,000 women with undiagnosed cancer. In some cases, women who took the blood test were able to have treatment to potentially cure the cancer. The researchers at the Johns Hopkins Kimmel Cancer Center in […]

Read more
news

RGCC Investigates Potential Treatments and Tests for COVID-19

As the world tries to cope with the rise in cases of covid-19 during the coronavirus pandemic, drug companies are racing to develop treatments that could reduce the number of deaths from the illness. This includes the specialist medical genetic testing company RGCC, which has turned its expertise and technology in the diagnosis and treatment […]

Read more
news

Blood test shows promise in detecting 50 cancers

Researchers have developed a blood test that can detect more than 50 common and deadly cancers, often before symptoms appear. The test could be especially useful in 12 cancers it was most accurate at detecting. These included pancreatic cancer, which is often only diagnosed at a very late stage and has poor outcomes and survival. […]

Read more
news

New test could spot early signs of prostate cancer

Researchers have used genetic testing to detect the very early changes that occur in the tumours of men with prostate cancer. Researchers at the University College London (UCL) Cancer Institute say the new type of blood test will help them understand the genetic characteristics of the tumours that cause prostate cancer, which is the second […]

Read more
news

Study shows genetic changes can occur years before diagnosis

A study suggests the genetic changes that cause cancers can happen years or even decades before the disease is diagnosed. A large analysis by an international team of researchers revealed that many DNA mutations – the changes in our genome that can trigger a tumour to develop – can occur long before someone is diagnosed […]

Read more
news

Circulating tumour DNA tests predictive in pancreatic cancer

More evidence is emerging to support the use of testing for circulating tumour DNA (ctDNA) as a promising way to predict whether a cancer will come back. Tumours release degraded fragments of DNA, including ctDNA, into the bloodstream. Testing a cancer patient’s blood for this DNA, using a type of blood test called a liquid […]

Read more
news

Liquid biopsy potential to guide colorectal cancer treatment

In the future, liquid biopsy testing is likely to play an increasing role in identifying which patients with colorectal cancer are most likely to have their cancer come back again after surgery. Liquid biopsy testing could also help doctors to decide which treatments would be most suitable to recommend to individual patients, according to new […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more